Dan Broderick is a managing director at Prolog.

Dan has nearly 20 years of experience in early-stage investing, venture fund management, and technology commercialization. He currently concentrates on specialty pharmaceuticals and analytical platforms and services. He came to Prolog from Mason Wells Private Equity, which he joined after launching a corporate venture capital fund and serving as the director of technology commercialization at the Mayo Clinic. Dan holds a bachelor’s degree in biology from Iowa State University.

Selected Portfolio Companies
-----------------------------------------------------------------------------------------
Asoyia            EraGen
CS-Keys